Post-Traumatic Stress Disorder (PTSD) Among Algerian Cancer Patients: Validity of the Arabic DSM-5 PTSD Checklist (PCL-5) and Associated Factors.

IF 3.3 2区医学 Q2 ONCOLOGY

Psycho‐Oncology Pub Date : 2025-02-01 DOI:10.1002/pon.70109

Aiche Sabah, Fethi Hammadi, Chiu-Hsiang Lee, Musheer A Aljaberi, Monique van Dijk, Chung-Ying Lin, Mark D Griffiths

{"title":"Post-Traumatic Stress Disorder (PTSD) Among Algerian Cancer Patients: Validity of the Arabic DSM-5 PTSD Checklist (PCL-5) and Associated Factors.","authors":"Aiche Sabah, Fethi Hammadi, Chiu-Hsiang Lee, Musheer A Aljaberi, Monique van Dijk, Chung-Ying Lin, Mark D Griffiths","doi":"10.1002/pon.70109","DOIUrl":null,"url":null,"abstract":"Background: Cancer patients are at risk of post-traumatic stress disorder (PTSD) throughout their treatment journey due to serious challenges (e.g., complex surgical interventions, severe pain, and side effects from chemotherapy or radiation therapy). This may worsen patients' health and negatively impact their overall treatment journey and well-being. However, this area remains understudied in Algeria. Therefore, there is a need to understand the levels of PTSD symptoms and the associated factors among Algerian patients. To ensure accurate assessment and diagnosis, a validation study was conducted to confirm that the PTSD measurement instrument used was culturally appropriate for the Algerian context. The study's main objectives were to (i) determine the prevalence of PTSD among cancer patients in Algeria, (ii) validate the Arabic DSM-5 PTSD Checklist (PCL-5) among Algerian cancer patients, and (iii) explore the associations between demographic and clinical factors and PTSD among this population.Methods: The present study was cross-sectional and comprised 370 cancer patients. All participants were patients receiving treatment in oncology wards across various hospitals. All participants completed the PCL-5. Confirmatory factor analysis (CFA) was used to examine the factor structure of the PCL-5.Results: The PCL-5 was found to have a four-factor structure. Out of the 370 participants, 154 (41.6%) had PCL-5 scores below the cutoff of 31, indicating lower levels of PTSD symptoms; 216 participants (58.4%) had scores above this threshold, suggesting a likelihood of PTSD. Moreover, PTSD was significantly associated with patients' low educational attainment and more advanced stages of their disease.Conclusions: The findings indicated moderate to high PTSD symptoms among cancer patients in Algeria. Moreover, the Arabic PCL-5 demonstrated good psychometric properties confirming that it is a reliable and valid tool for assessing PTSD symptoms among Algerian cancer patients.","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70109"},"PeriodicalIF":3.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845313/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psycho‐Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pon.70109","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Cancer patients are at risk of post-traumatic stress disorder (PTSD) throughout their treatment journey due to serious challenges (e.g., complex surgical interventions, severe pain, and side effects from chemotherapy or radiation therapy). This may worsen patients' health and negatively impact their overall treatment journey and well-being. However, this area remains understudied in Algeria. Therefore, there is a need to understand the levels of PTSD symptoms and the associated factors among Algerian patients. To ensure accurate assessment and diagnosis, a validation study was conducted to confirm that the PTSD measurement instrument used was culturally appropriate for the Algerian context. The study's main objectives were to (i) determine the prevalence of PTSD among cancer patients in Algeria, (ii) validate the Arabic DSM-5 PTSD Checklist (PCL-5) among Algerian cancer patients, and (iii) explore the associations between demographic and clinical factors and PTSD among this population.

Methods: The present study was cross-sectional and comprised 370 cancer patients. All participants were patients receiving treatment in oncology wards across various hospitals. All participants completed the PCL-5. Confirmatory factor analysis (CFA) was used to examine the factor structure of the PCL-5.

Results: The PCL-5 was found to have a four-factor structure. Out of the 370 participants, 154 (41.6%) had PCL-5 scores below the cutoff of 31, indicating lower levels of PTSD symptoms; 216 participants (58.4%) had scores above this threshold, suggesting a likelihood of PTSD. Moreover, PTSD was significantly associated with patients' low educational attainment and more advanced stages of their disease.

Conclusions: The findings indicated moderate to high PTSD symptoms among cancer patients in Algeria. Moreover, the Arabic PCL-5 demonstrated good psychometric properties confirming that it is a reliable and valid tool for assessing PTSD symptoms among Algerian cancer patients.

查看原文本刊更多论文

阿尔及利亚癌症患者创伤后应激障碍（PTSD）：阿拉伯语DSM-5 PTSD检查表（PCL-5）的有效性及相关因素

背景：癌症患者在整个治疗过程中都面临着创伤后应激障碍（PTSD）的风险，因为他们面临着严峻的挑战（例如，复杂的手术干预、剧烈的疼痛以及化疗或放疗的副作用）。这可能会使患者的健康恶化，并对他们的整体治疗过程和福祉产生负面影响。然而，阿尔及利亚对这一领域的研究仍然不足。因此，有必要了解阿尔及利亚患者的创伤后应激障碍症状水平及其相关因素。为了确保准确的评估和诊断，进行了一项验证研究，以确认所使用的创伤后应激障碍测量工具在阿尔及利亚的文化背景下是合适的。该研究的主要目的是(i)确定阿尔及利亚癌症患者中PTSD的患病率，（ii）在阿尔及利亚癌症患者中验证阿拉伯语DSM-5 PTSD检查表（PCL-5），以及（iii）探索人口统计学和临床因素与该人群中PTSD之间的关系。方法：本研究采用横断面方法，纳入370例肿瘤患者。所有参与者都是在不同医院的肿瘤病房接受治疗的患者。所有参与者均完成PCL-5。采用验证性因子分析（CFA）检验PCL-5的因子结构。结果：PCL-5具有四因子结构。在370名参与者中，154名（41.6%）的PCL-5得分低于31分的临界值，表明PTSD症状水平较低；216名参与者（58.4%）的得分高于这一阈值，表明可能患有PTSD。此外，创伤后应激障碍与患者的低教育程度和疾病的晚期显著相关。结论：阿尔及利亚癌症患者存在中度至重度创伤后应激障碍症状。此外，阿拉伯语PCL-5表现出良好的心理测量特性，证实它是评估阿尔及利亚癌症患者创伤后应激障碍症状的可靠有效工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psycho‐Oncology 医学-心理学

CiteScore

6.30

自引率

8.30%

发文量

220

审稿时长

3-8 weeks

期刊介绍： Psycho-Oncology is concerned with the psychological, social, behavioral, and ethical aspects of cancer. This subspeciality addresses the two major psychological dimensions of cancer: the psychological responses of patients to cancer at all stages of the disease, and that of their families and caretakers; and the psychological, behavioral and social factors that may influence the disease process. Psycho-oncology is an area of multi-disciplinary interest and has boundaries with the major specialities in oncology: the clinical disciplines (surgery, medicine, pediatrics, radiotherapy), epidemiology, immunology, endocrinology, biology, pathology, bioethics, palliative care, rehabilitation medicine, clinical trials research and decision making, as well as psychiatry and psychology. This international journal is published twelve times a year and will consider contributions to research of clinical and theoretical interest. Topics covered are wide-ranging and relate to the psychosocial aspects of cancer and AIDS-related tumors, including: epidemiology, quality of life, palliative and supportive care, psychiatry, psychology, sociology, social work, nursing and educational issues. Special reviews are offered from time to time. There is a section reviewing recently published books. A society news section is available for the dissemination of information relating to meetings, conferences and other society-related topics. Summary proceedings of important national and international symposia falling within the aims of the journal are presented.